SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
SBI Holdings, Inc.

(Last) (First) (Middle)
IZUMI GARDEN TOWER 19F, 1-6-1 ROPPONGI
MINATO-KU

(Street)
TOKYO M0 106-6019

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD [ NONE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/28/2017
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/28/2017 J(1) 6,196,869 D $49,711,631.43(2) 0 D
Common Stock 02/28/2017 J(1) 6,196,869 A $49,711,631.43(2) 14,486,625 I By SBI Incubation Co., Ltd.(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
SBI Holdings, Inc.

(Last) (First) (Middle)
IZUMI GARDEN TOWER 19F, 1-6-1 ROPPONGI
MINATO-KU

(Street)
TOKYO M0 106-6019

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
SBI Incubation Co., Ltd.

(Last) (First) (Middle)
IZUMI GARDEN TOWER 19F
1-6-1 ROPPONGI, MINATO-KU

(Street)
TOKYO M0 106-6019

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. Intra-company transfer from SBI Holdings, Co. Ltd. to SBI Incubation Co., Ltd. SBI Incubation Co., Ltd. is an indirect wholly-owned subsidiary of SBI Holdings, Inc.
2. The shares were purchased at a price of 5,589,575,838 Japanese Yen. The purchase price reported above is reflected in US Dollars, based on the Mizuho TTM rate in effect on the date of purchase, rounded to the nearest whole cent.
3. These shares are held directly by SBI Incubation Co., Ltd. SBI Holdings, Inc. may be deemed to be the indirect beneficial owner of these securities.
Remarks:
SBI Holdings, Inc. By: /s/ Yoshitaka Kitao, Representative Director, President & CEO 03/08/2017
SBI Incubation Co., Ltd. By: /s/ Shumpei Morita, Representative Director 03/08/2017
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.